These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 3569414

  • 21. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR.
    Brain Res; 1982 Feb 18; 234(1):123-36. PubMed ID: 7059818
    [Abstract] [Full Text] [Related]

  • 22. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
    Umino A, Takahashi K, Nishikawa T.
    Br J Pharmacol; 1998 May 18; 124(2):377-85. PubMed ID: 9641556
    [Abstract] [Full Text] [Related]

  • 23. Effects of phencyclidine in combination with morphine on the levels of met-enkephalin, dopamine, DOPAC and HVA in discrete brain areas of mice.
    Nabeshima T, Hiramatsu M, Furukawa H, Kameyama T.
    Neuropharmacology; 1985 Aug 18; 24(8):805-9. PubMed ID: 3837860
    [Abstract] [Full Text] [Related]

  • 24. Antagonism of ceruletide, a cholecystokinin analog, to the neurochemical effects of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, phencyclidine and MK-801, on regional dopaminergic neurons in the rat brain.
    Kuroki T, Tatebayashi Y, Ide K, Yonezawa Y, Tsutsumi T, Matsumoto T, Hirano M, Uchimura H.
    Neuropeptides; 1992 Mar 18; 21(3):167-73. PubMed ID: 1385857
    [Abstract] [Full Text] [Related]

  • 25. Stimulation of the rat mesolimbic dopaminergic system produces a pressor response which is mediated by dopamine D-1 and D-2 receptor activation and the release of vasopressin.
    Cornish JL, van den Buuse M.
    Brain Res; 1995 Dec 01; 701(1-2):28-38. PubMed ID: 8925292
    [Abstract] [Full Text] [Related]

  • 26. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y, Mitsushio H, Takahashi K, Nishikawa T.
    Synapse; 2000 Mar 15; 35(4):292-9. PubMed ID: 10657039
    [Abstract] [Full Text] [Related]

  • 27. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP, Leone P, Pocock D, Wise RA.
    J Pharmacol Exp Ther; 1993 Sep 15; 266(3):1236-46. PubMed ID: 7690399
    [Abstract] [Full Text] [Related]

  • 28. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.
    Hefti F, Melamed E, Wurtman RJ.
    Brain Res; 1980 Aug 11; 195(1):123-37. PubMed ID: 6105003
    [Abstract] [Full Text] [Related]

  • 29. Reversal of the actions of morphine on mesocortical dopamine metabolism in the rat by the kappa agonist MR-2034: tentative mu-2 opioid control of mesocortical dopaminergic projections.
    Kim HS, Iyengar S, Wood PL.
    Life Sci; 1987 Oct 05; 41(14):1711-5. PubMed ID: 2821337
    [Abstract] [Full Text] [Related]

  • 30. Release of dopamine in the ventral tegmental area of rat.
    Fadda F, Melis MR, Argiolas A, Perra G.
    Boll Soc Ital Biol Sper; 1979 Jul 15; 55(12):1178-83. PubMed ID: 553533
    [Abstract] [Full Text] [Related]

  • 31. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis.
    Nishijima K, Kashiwa A, Hashimoto A, Iwama H, Umino A, Nishikawa T.
    Synapse; 1996 Apr 15; 22(4):304-12. PubMed ID: 8867025
    [Abstract] [Full Text] [Related]

  • 32. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M, Mataga N, Takashima M, Nishikawa T.
    Psychopharmacology (Berl); 1981 Apr 15; 74(4):316-20. PubMed ID: 6794073
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Differences in effects of Ca2+ channel antagonists on dopamine metabolism in the limbic and extrapyramidal dopaminergic structures.
    Antkiewicz-Michaluk L, Romańska I, Vetulani J.
    Psychopharmacology (Berl); 1996 Nov 15; 128(1):39-44. PubMed ID: 8944404
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons.
    Julou L, Scatton B, Glowinski J.
    Adv Biochem Psychopharmacol; 1977 Nov 15; 16():617-24. PubMed ID: 18904
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.
    Ahtee L, Kaakkola S.
    Br J Pharmacol; 1978 Feb 15; 62(2):213-8. PubMed ID: 564219
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.